| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 28, 2020 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | President &CEO | Sell | 243,518 | $125.23 | $30,495,275.94 | -1.6% | |
| Jul 27, 2020 | TMO Thermo Fisher Scientific Inc. | Jafry Syed A. | Sr. Vice President | Sell | 20,513 | $414.94 | $8,511,646.19 | -11.9% | |
| Jul 27, 2020 | DHR Danaher Corp /de/ | Weidemanis Joakim67 | Executive Vice President | Sell | 19,834 | $196.00 | $3,887,464.00 | -17.6% | |
| Jul 27, 2020 | DHR Danaher Corp /de/ | Hefner Linda P58 | Director | Sell | 2,754 | $197.00 | $542,538.00 | -8.4% | |
| Jul 27, 2020 | DHR Danaher Corp /de/ | Comas Daniel L | EVP | Sell | 100,032 | $194.56 | $19,461,980.23 | -6.3% | |
| Jul 27, 2020 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 40,000 | $403.89 | $16,155,400.00 | -7.7% | |
| Jul 24, 2020 | TMO Thermo Fisher Scientific Inc. | Stevenson Mark59 | Executive Vice President &COO | Sell | 25,000 | $404.58 | $10,114,465.34 | -5.3% | |
| Jul 24, 2020 | DHR Danaher Corp /de/ | Joyce Thomas Patrick Jr | President And CEO | Sell | 181,394 | $193.98 | $35,186,837.30 | -5.7% | |
| Jul 24, 2020 | TMO Thermo Fisher Scientific Inc. | Manzi Jim P52 | Director | Sell | 3,218 | $402.38 | $1,294,865.40 | -2.6% | |
| Jul 24, 2020 | DHR Danaher Corp /de/ | Schwieters John T | Director | Sell | 6,014 | $193.95 | $1,166,403.07 | -5.1% | |
| Jul 24, 2020 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 66,123 | $108.87 | $7,198,569.09 | -0.4% | |
| Jul 24, 2020 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | President &CEO | Sell | 66,123 | $108.87 | $7,198,569.09 | -0.4% | |
| Jul 23, 2020 | VCYT Veracyte, Inc. | Anderson Bonnie H72 | Chairman And CEO | Sell | 3,280 | $32.04 | $105,106.29 | -1.2% | |
| Jul 22, 2020 | IQV Iqvia Holdings Inc. | Bousbib Ari64 | See Remarks | Sell | 46,080 | $160.00 | $7,372,800.00 | -6.6% | |
| Jul 22, 2020 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 7,500 | $40.70 | $305,222.08 | -0.2% | |
| Jul 22, 2020 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 63,968 | $108.58 | $6,945,671.42 | -0.4% | |
| Jul 22, 2020 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 12,000 | $40.97 | $491,657.20 | -0.1% | |
| Jul 22, 2020 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | President &CEO | Sell | 63,968 | $108.58 | $6,945,671.42 | -0.4% | |
| Jul 22, 2020 | VCYT Veracyte, Inc. | Anderson Bonnie H72 | Chairman And CEO | Sell | 23,896 | $32.04 | $765,724.28 | -2.8% | |
| Jul 21, 2020 | VCYT Veracyte, Inc. | Hanna John Walter Jr | Chief Commercial Officer | Sell | 11,947 | $32.07 | $383,124.11 | -7.4% | |
| Jul 20, 2020 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | President &CEO | Sell | 37,044 | $105.39 | $3,904,134.33 | -0.2% | |
| Jul 20, 2020 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 37,044 | $105.39 | $3,904,134.33 | -0.2% | |
| Jul 17, 2020 | CSTL Castle Biosciences Inc | Kabakoff David S74 | Director | Sell | 25,000 | $43.04 | $1,075,900.00 | -2.1% | |
| Jul 17, 2020 | CSTL Castle Biosciences Inc | Anderson Bonnie H72 | Director | Sell | 3,000 | $43.55 | $130,658.74 | -4.3% | |
| Jul 16, 2020 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 43,973 | $104.48 | $4,594,440.10 | -0.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.